Evan Vucci / AP

Sean Spicer just finished today's White House press briefing, raising eyebrows on topics from those wiretapping claims, Mike Flynn seeking immunity, sanctuary cities, questions on Russia, tax returns, and the failure of Trumpcare. Highlights below:

  • Trump's wiretapping claims: Spicer suggested we are seeing "more and more" evidence on the issue, adding that a "senior Obama administration official [Evelyn Farkas] talked about the spreading of classified information... and no one seems to care!"
  • Nunes' surveillance claims: Spicer insists what happened with Rep. Devin Nunes was "both routine and proper," and reiterated they're worried about "the substance, unmasking and leaks." Spicer also confirmed that Rep. Adam Schiff will visit the WH later today to review the intelligence documents.
  • Mike Flynn's request for immunity: Spicer said Trump wants Flynn to testify to Congress about Russia, saying he "wasn't offering legal advice" in his tweet. As for whether Trump is concerned Flynn will reveal damaging information about him, Spicer replied, "Nope."
  • The failure of Trumpcare: "I would dispute that we signed onto someone's plan," said Spicer. "We worked with the House. We were very on-board."
  • The Russia probe: The only evidence of any Trump-Russia connection is the Miss Universe pageant years ago, said Spicer, who added that Hillary Clinton's ties with Russia have not been questioned as much as Trump's.
  • On backing off of Assad and Syria: Spicer said we have to accept the "reality" that Assad will stay, and blamed the Obama administration for missing the opportunity to oust him.
  • Trump's tax returns: Spicer dodged questions on whether Trump will release his 2016 tax returns, but noted that the WH is "blessed" to have people who are giving up assets and are willing to undergo financial scrutiny.
  • Trade executive orders: Spicer said Trump is calling for an investigation into "unfair trade practices," and said "this is the first time in modern history a president has ordered a review of reasons for the trade deficit."
  • Sanctuary cities: When asked if cutting federal funding to sanctuary cities, such as in Chicago, hurts the police's attempts to curb violence, Spicer said, "You can't be a sanctuary city and… seem to pretend or express concern about law enforcement."

Go deeper

Updated 16 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Global: Total confirmed cases as of 6:30 p.m. ET: 20,177,521 — Total deaths: 738,716 — Total recoveries: 12,400,156Map.
  2. U.S.: Total confirmed cases as of 6:30 p.m. ET: 5,130,784 — Total deaths: 164,603 — Total recoveries: 1,670,755 — Total tests: 62,513,174Map.
  3. States: Georgia reports 137 coronavirus deaths, setting new daily record Florida reports another daily record for deaths.
  4. Health care: Trump administration buys 100 million doses of Moderna's coronavirus vaccine.
  5. Business: Moderna reveals it may not hold patent rights for vaccine.
  6. Sports: Big Ten scraps fall football season.

Voters cast ballots in Minnesota, Georgia, Connecticut, Wisconsin and Vermont

Photo: Spencer Platt/Getty Images

Primary elections are being held on Tuesday in Minnesota, Georgia, Connecticut, Vermont and Wisconsin.

The big picture: Georgia and Wisconsin both struggled to hold primaries during the coronavirus pandemic, but are doing so again — testing their voting systems ahead of the general election. Rep. Ilhan Omar (D-Minn.) is facing a strong challenger as she fights for her political career. In Georgia, a Republican primary runoff pits a QAnon supporter against a hardline conservative.

45 mins ago - Health

Trump administration buys 100 million doses of Moderna's vaccine

A volunteer in Moderna's vaccine clinical trial receives a shot. Photo: Paul Hennessy/NurPhoto via Getty Images

The U.S. government has agreed to buy 100 million doses of Moderna's experimental coronavirus vaccine for $1.5 billion, or $15 per dose.

Why it matters: The Trump administration, through Operation Warp Speed, has now bought initial batches of vaccines from Moderna, GlaxoSmithKline and Sanofi, Pfizer, Novavax, Johnson & Johnson and AstraZeneca before knowing whether they are safe and effective. The federal government also appears to own some of the patent rights associated with Moderna's vaccine.